May 12, 2026 08:45AM
May 12, 2026 06:30AM
Mar 25, 2026 08:00AM
Mar 18, 2026 08:00AM
Mar 18, 2026 08:00AM
Jan 30, 2026 08:00AM
Jan 30, 2026 08:00AM ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
Dec 18, 2025 07:30AM
Dec 18, 2025 07:30AM
Dec 10, 2025 07:30AM
Dec 10, 2025 07:30AM
Dec 1, 2025 07:30AM
Dec 1, 2025 07:30AM
Nov 24, 2025 08:00AM ProMIS Neurosciences implements 1-for-25 reverse stock split
Nov 24, 2025 08:00AM
Nov 12, 2025 07:09AM
Nov 12, 2025 07:00AM
Nov 12, 2025 07:00AM
Oct 22, 2025 07:31AM
Oct 22, 2025 07:30AM
Sep 3, 2025 07:00AM ProMIS Neurosciences advances to final dose cohort in alzheimer's trial
Sep 3, 2025 07:00AM
Aug 13, 2025 06:51PM
Aug 13, 2025 07:00AM
Aug 13, 2025 07:00AM
Jul 29, 2025 08:00AM
Jul 29, 2025 08:00AM
Jul 28, 2025 07:01AM ProMIS Neurosciences raises $12 million through warrant financing
Jul 28, 2025 07:00AM
Jul 22, 2025 08:53AM
Jul 22, 2025 07:01AM
Jul 22, 2025 07:00AM
Jul 21, 2025 08:04AM
Jul 21, 2025 08:00AM
May 13, 2025 06:33AM ProMIS Neurosciences, Inc. (PMN) Misses Q1 EPS by 6c
May 12, 2025 07:30AM
Mar 31, 2025 07:00AM
Mar 24, 2025 07:01AM
Mar 24, 2025 07:00AM
Mar 13, 2025 07:00AM
Mar 13, 2025 07:00AM
Feb 25, 2025 07:01AM ProMIS Neurosciences (PMN) Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease
Feb 25, 2025 07:00AM
Jan 13, 2025 10:40AM
Jan 13, 2025 10:30AM
Jan 10, 2025 07:03AM
Jan 10, 2025 07:00AM
Nov 14, 2024 05:20PM
Nov 14, 2024 09:15AM ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
Oct 30, 2024 08:01AM

1,197,396 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All